Cashu
Abzena Recognized as Leader in Antibody-Drug Conjugate Manufacturing by Frost & Sullivan
about 18 hours ago
Stocks
Health Care
cdmo
Avid Bioservices
NASDAQ: CDMO
0.00 (0.00%)
0
USD
At close at Mar 18, 13:27 UTC
Latest Avid Bioservices News
prnewswire.com
Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report
1 day ago
prnewswire.com
BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
5 days ago
prnewswire.com
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
7 days ago
prnewswire.com
mAbxience Selects Genedata Bioprocess to Automate End-to-End CDMO Workflows
8 days ago
prnewswire.com
Akums verstrkt Prsenz in Europa und Grobritannien - Indiens grter CDMO erweitert globale Reichweite
22 days ago
prnewswire.com
Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint
23 days ago
prnewswire.com
Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint
23 days ago
prnewswire.com
Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
2 months ago
prnewswire.com
Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program
3 months ago
prnewswire.com
GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody Program
3 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.